We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.275 | 3.25 | 3.30 | 3.275 | 3.275 | 3.28 | 141,816 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.75 | 1.94M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2023 08:29 | Wrong spread x is in grey. There is no way they will accept a position on any share in grey. | luckyabbeygale | |
04/12/2023 08:23 | You should try again with SpreadEx they will accept positions. IG will only accept positions in professional accounts | jaknife | |
04/12/2023 08:18 | That is lies. I have tried to buy fab on a spread bet using spread x or with ig index for over a year now. They both say it is closing only. | luckyabbeygale | |
04/12/2023 08:12 | luckyabbeygale, "No one is going to put in their ig user name and password just for you to hack their account." That is the IG page for FAB, which clearly contradicts your claim in post 3,653 that "No one holds this stock on a spread bet or on a cfd." JakNife | jaknife | |
04/12/2023 08:09 | No one is going to put in their ig user name and password just for you to hack their account. | luckyabbeygale | |
04/12/2023 08:09 | I do hold a small sb but it’s impossible to add to it , close only | cbeadle | |
04/12/2023 07:57 | No one holds this stock on a spread bet or on a cfd. Therefore the drop is at no loss to us and is a huge buying opportunity. | luckyabbeygale | |
01/12/2023 10:03 | Good find Thiopia and thanks. | mcbull | |
30/11/2023 16:48 | See header thiopia :-) | lawson27 | |
30/11/2023 14:40 | Googling 'Mammalian Cell Display' brings up the name of a long time academic researcher on the area dating back to 2009 in terms of published research... Mitchell Ho Guess who is the Director of the Research on Antibody Engineering (Mammalian Cell Display) at US NCI and on the Fusion Antibodies FAB RNS ? Mitchell Ho !!! I think people are underestimating just how big a deal this could be for FAB US Govt NCI just provides one level of validation but an important on (as well as having a multi-billion budget) but this should lead to lots of Bios and Pharmas also beating a path to FAB's door | thiopia | |
30/11/2023 12:31 | Only have to look at the chart to see how much the share price has been squeezed down that RNS was a game changer | bobaxe1 | |
30/11/2023 12:14 | I wonder if they will go past 9p again this time round. | luckyabbeygale | |
29/11/2023 12:55 | I nearly brought yesterday, but managed to control my FOMO for once. It's good news though. | montyhedge | |
29/11/2023 12:53 | Good news, but no revenue in rns. | montyhedge | |
29/11/2023 09:46 | Apta is next ;) news due very soon | goldennuggets87 | |
29/11/2023 09:34 | Watch out for another cash raise, as they might need it to take the project forward. DYOR. | clocktower | |
29/11/2023 09:18 | I know, I've had a buy order in for the last hour through trading 212 which hasn't been filled | ih_732280 | |
29/11/2023 09:16 | It's only 4 mill mcap ridiculous with collaboration with largest cancer research facility in world with multimillion funding just think where this can go from here where else would you find better to invest hold on for gold here | mally6 | |
29/11/2023 08:08 | Not trading for 15 mins, what's that about? | ih_732280 | |
29/11/2023 07:37 | Get ready for take off 🚀🚀 | smraynot | |
28/11/2023 22:25 | NCI is operating under a continuing resolution (CR) that provides funding from October 1, 2023 through February 2, 2024, at the same level as fiscal year 2023. The Consolidated Appropriations Act, 2023, allocated $7.3 billion to NCI, including $216 million for the NCI component of the Cancer Moonshot?.20 Nov 2023 | mally6 | |
28/11/2023 22:17 | NCI RevenueNeo-Concept International Group Holdings had revenue of $233.10M in the twelve months ending June 30, 2023. In the year 2022, Neo-Concept International Group Holdings had annual revenue of $347.45M with 44.45% growth.Revenue (ttm)233.10M HKDRevenue Growth+44.45%Collabo | mally6 | |
28/11/2023 19:25 | Volume on breakout of the 50 Day Moving Average is huge Scope for a lot more upside on the chart with 200 day Moving Average another 100%+ higher than today's closing price | thiopia |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions